The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Abstract
It is now clear that PCOS is often associated with profound insulin resistance as well as with defects in insulin secretion. These abnormalities, together with obesity, explain the substantially increased prevalence of glucose intolerance in PCOS. Moreover, since PCOS is an extremely common disorder, PCOS-related insulin resistance is an important cause of NIDDM in women (Table 3). The insulin resistance in at least 50% of PCOS women appears to be related to excessive serine phosphorylation of the insulin receptor. A factor extrinsic to the insulin receptor, presumably a serine/threonine kinase, causes this abnormality and is an example of an important new mechanism for human insulin resistance related to factors controlling insulin receptor signaling. Serine phosphorylation appears to modulate the activity of the key regulatory enzyme of androgen biosynthesis, P450c17. It is thus possible that a single defect produces both the insulin resistance and the hyperandrogenism in some PCOS women (Fig. 19). Recent studies strongly suggest that insulin is acting through its own receptor (rather than the IGF-I receptor) in PCOS to augment not only ovarian and adrenal steroidogenesis but also pituitary LH release. Indeed, the defect in insulin action appears to be selective, affecting glucose metabolism but not cell growth. Since PCOS usually has a menarchal age of onset, this makes it a particularly appropriate disorder in which to examine the ontogeny of defects in carbohydrate metabolism and for ascertaining large three-generation kindreds for positional cloning studies to identify NIDDM genes. Although the presence of lipid abnormalities, dysfibrinolysis, and insulin resistance would be predicted to place PCOS women at high risk for cardiovascular disease, appropriate prospective studies are necessary to directly assess this.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results
Lander, E., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,239
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., & Soltoff, S. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,694
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citationBergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 3×
“NIDDM develops when the compensatory increase in insulin levels is no longer sufficient to maintain euglycemia (72, 73).”
BackgroundStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling
Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J.-H., Masiarz, F., Kan, Y. W., Goldfine, I. D., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90334-4 · Cited by 1,477
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Insulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,126
The Syndromes of Insulin Resistance and Acanthosis Nigricans: Insulin-Receptor Disorders in Man
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., & Roth, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941401 · Cited by 1,106
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Cheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902 · Cited by 1,068
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001
Leptin: The Tale of an Obesity Gene
Caro, J. F., Sinha, M. K., Kolaczynski, J. W., Li Zhang, P., & Considine, R. V. (1996) · Diabetes · doi:10.2337/diab.45.11.1455 · Cited by 982
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921 · cited 2×
“As little as a 7% reduction in body weight can restore fertility in obese PCOS women (270), and this should be encouraged in all overweight PCOS women.”
BackgroundResultCorrelation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
BURGHEN, G. A., GIVENS, J. R., & KITABCHI, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 918
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Insulin Action and the Insulin Signaling Network*
CHEATHAM, B., & KAHN, C. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-117 · Cited by 881
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Kemp, B. E., Graves, D. J., Benjamini, E., & Krebs, E. G. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40137-2 · Cited by 835
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Insulin-like Growth Factor Binding Proteins
Rechler, M. M. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60444-6 · Cited by 755
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735
How good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Cochet, C., Gill, G. N., Meisenhelder, J., Cooper, J. A., & Hunter, T. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43389-8 · Cited by 711
Santen, R. J., & Bardin, C. W. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107454 · Cited by 706
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
YEN, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 698
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595 · cited 2×
“There is clearly genetic heterogeneity with insulin resistance being absent in some affected individuals (146, 147).”
BackgroundHanis, C. L., Boerwinkle, E., Chakraborty, R., Ellsworth, D. L., Concannon, P., Stirling, B., Morrison, V. A., Wapelhorst, B., Spielman, R. S., Gogolin-Ewens, K. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-161 · Cited by 590
DUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586
Self-citationDunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 9×
“with abnormal phosphorylation, insulin receptor phosphorylation in fibroblasts and skeletal muscle from these women is similar to that of control women (69).”
BackgroundResultInfluentialSelf-citationDahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., & Odén, A. (1992) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349209006227 · Cited by 548
Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Shelley, D. R., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 546
Self-citationDahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P., Mattson, L.-A., Crona, N., & Lundberg, P.-A. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90704-m · Cited by 527
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
Self-citationCoronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E., Guzick, D., Clerici, A., Berga, S., Detre, K., Weimer, K., & Kuller, L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 504
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Tattersall, R. B., Fajans, S. S., & Arbor, A. (1975) · Diabetes · doi:10.2337/diab.24.1.44 · Cited by 475
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Odén, A., Janson, P. O., Mattson, L.-Å., Crona, N., & Lundberg, P.-A. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54892-4 · Cited by 470
Androgens in Men — Uses and Abuses
Bagatell, C. J., & Bremner, W. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341107 · Cited by 464
Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S., & Williamson, R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.10.1873 · Cited by 463
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Morales, A. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2854 · Cited by 455
Zhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Dunaif, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.942 · Cited by 450
Self-citationThe Gonadotropic Function of Insulin*
PORETSKY, L., & KALIN, M. F. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-132 · Cited by 447
Carmina, E., Koyama, T., Chang, L., Stanczyk, F. Z., & Lobo, R. A. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91779-a · Cited by 444
Flier, J. S., Kahn, C. R., Roth, J., & Bar, R. S. (1975) · Science · doi:10.1126/science.170678 · Cited by 438
Holte, J., Bergh, T., Berne, C., Wide, L., & Lithell, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673399 · Cited by 435
The Molecular Mechanism of Insulin Action
Kahn, C. R. (1985) · Annual Review of Medicine · doi:10.1146/annurev.me.36.020185.002241 · Cited by 431
Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis”
HUGHESDON, P. E. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198202000-00001 · Cited by 429
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies
Hull, M. G. R. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709023610 · Cited by 427
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
Conway, G. S., Agrawal, R., Betteridge, D. J., & Jacobs, H. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02295.x · Cited by 427
Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118064 · Cited by 426
Racial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1294 · Cited by 408
WALDSTREICHER, J., SANTORO, N. F., HALL, J. E., FILICORI, M., & CROWLEY, W. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-165 · Cited by 407
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 401
Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitus
Kissebah, A. H., & Peiris, A. N. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050202 · Cited by 389
YEN, S. S. C., VELA, P., & RANKIN, J. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-4-435 · Cited by 389
Induction of insulin resistance by androgens and estrogens
Polderman, K. H. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.265 · Cited by 380
Conte, F. A., Grumbach, M. M., Ito, Y., Fisher, C. R., & Simpson, E. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.8200927 · Cited by 379
Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371 · cited 1×
“Moreover, these actions appear to be preserved in insulin-resistant states (193, 194), presumably because of differences in receptor sensitivity to this insulin action or because of differential regulation of the receptor in this tissue.”
BackgroundInsulin Action During Pregnancy: Studies with the Euglycemic Clamp Technique
Ryan, E. A., O'Sullivan, M. J., & Skyler, J. S. (1985) · Diabetes · doi:10.2337/diab.34.4.380 · Cited by 369
The Polycystic Ovary. I. Clinical and Histologic Features
GOLDZIEHER, J. W., & GREEN, J. A. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-3-325 · Cited by 367
Habershon, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)93067-6 · Cited by 367
ADASHI, E. Y., HSUEH, A. J. W., & YEN, S. S. C. (1981) · Endocrinology · doi:10.1210/endo-108-4-1441 · Cited by 366
Relationship between degree of obesity and in vivo insulin action in man
Bogardus, C., Lillioja, S., Mott, D. M., Hollenbeck, C., & Reaven, G. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e286 · Cited by 344
NESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336
Ehrmann, D. A., Cavaghan, M. K., Imperial, J., Sturis, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3722 · Cited by 336
Risma, K. A., Clay, C. M., Nett, T. M., Wagner, T., Yun, J., & Nilson, J. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1322 · Cited by 328
Birdsall, M. A., Farquhar, C. M., & White, H. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00005 · Cited by 327 · cited 2×
“The women with PCO also have higher free testosterone, triglyceride, and C-peptide levels and lower LDL levels than the women with normal ovaries, suggesting that they have both the endocrine and the metabolic derangements of PCOS (251).”
BackgroundDetection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess
Ehrmann, D. A., Rosenfield, R. L., Barnes, R. B., Brigell, D. F., & Sheikh, Z. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270304 · Cited by 327
Rothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
Waterworth, D. M., Bennett, S. T., Gharani, N., McCarthy, M. I., Hague, S., Batty, S., Conway, G. S., White, D., Todd, J. A., Franks, S., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08368-7 · Cited by 318
Takayama, S., White, M. F., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69090-8 · Cited by 317
Myers, M. G., Sun, X. J., & White, M. F. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90007-8 · Cited by 315
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Mutations in the Insulin Receptor Gene
TAYLOR, S. I., CAMA, A., ACCILI, D., BARBETTI, F., QUON, M. J., SIERRA, M. D. L. L., SUZUKI, Y., ROLLER, E., LEVY-TOLEDANO, R., WERTHEIMER, E., et al. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-566 · Cited by 311
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus
Maddux, B. A., Sbraccia, P., Kumakura, S., Sasson, S., Youngren, J., Fisher, A., Spencer, S., Grupe, A., Henzel, W., Stewart, T. A., et al. (1995) · Nature · doi:10.1038/373448a0 · Cited by 309
HOLLENBECK, C., & REAVEN, G. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1169 · Cited by 307
Crave, J. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2057 · Cited by 302
Gerbitz, K.-D., Gempel, K., & Brdiczka, D. (1996) · Diabetes · doi:10.2337/diab.45.2.113 · Cited by 296
Barbieri, R. L., & Ryan, K. J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90091-1 · Cited by 294
Association of the Steroid Synthesis Gene Cyp11a with Polycystic Ovary Syndrome and Hyperandrogenism
Gharani, N., Waterworth, D. M., Batty, S., White, D., Gilling-Smith, C., Conway, G. S., McCarthy, M., Franks, S., & Williamson, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.3.397 · Cited by 294
Sasaoka, T., Rose, D. W., Jhun, B. H., Saltiel, A. R., Draznin, B., & Olefsky, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36885-0 · Cited by 291
Holte, J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1052 · Cited by 290
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
Carey, A. H., Chan, K. L., Short, F., White, D., Williamson, R., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02150.x · Cited by 285
Robinson, S., Kiddy, D., Gelding, S. V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D. G., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02376.x · Cited by 283
CLINICAL REVIEW 26 Insulin Resistance in Obese and Nonobese Man
CARO, J. F. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-691 · Cited by 279
Bollag, G. E., Roth, R. A., Beaudoin, J., Mochly-Rosen, D., & Koshland, D. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5822 · Cited by 273
In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians
Lillioja, S., Mott, D. M., Zawadzki, J. K., Young, A. A., Abbott, W. G. H., Knowler, W. C., Bennett, P. H., Moll, P., & Bogardus, C. (1987) · Diabetes · doi:10.2337/diab.36.11.1329 · Cited by 269
Insulin-like growth factors and insulin: comparative aspects
Froesch, E. R., & Zapf, J. (1985) · Diabetologia · doi:10.1007/bf00281982 · Cited by 262
On the Paradox of Insulin-Induced Hyperandrogenism in Insulin-Resistant States
PORETSKY, L. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-3 · Cited by 262
Insulin-like Growth Factor I Receptor β-Subunit Heterogeneity
Moxham, C. P., Duronio, V, & Jacobs, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51620-3 · Cited by 260
Nuutila, P., Knuuti, M. J., Mäki, M., Laine, H., Ruotsalainen, U., Teräs, M., Haaparanta, M., Solin, O., & Yki-Järvinen, H. (1995) · Diabetes · doi:10.2337/diab.44.1.31 · Cited by 253
Insulin resistance, secretion, and metabolism in users of oral contraceptives
Godsland, I. F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.1.64 · Cited by 251
Ehrmann, D. A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.524 · Cited by 250
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
Guzick, D. S., Wing, R., Smith, D., Berga, S. L., & Winters, S. J. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56632-1 · Cited by 246
Moghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.952 · Cited by 245
Defects in beta-cell function in functional ovarian hyperandrogenism
O'Meara, N. M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1241 · Cited by 245
Patti, M.-E., Sun, X.-J., Bruening, J. C., Araki, E., Lipes, M. A., White, M. F., & Kahn, C. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24670 · Cited by 238
Epidemiology of secondary amenorrhea
Pettersson, F., Fries, H., & Nillius, S. J. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(73)90732-1 · Cited by 238
ACANTHOSIS NIGRICANS: A STUDY OF 90 CASES
BROWN, J., & WINKELMANN, R. K. (1968) · Medicine · doi:10.1097/00005792-196801000-00002 · Cited by 237
Dunaif, A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80057-6 · Cited by 236
Self-citationEffects of Body Composition on Insulin Sensitivity
Yki-Järvinen, H., & Koivisto, V. A. (1983) · Diabetes · doi:10.2337/diab.32.10.965 · Cited by 232
Rosenbaum, D., Haber, R. S., & Dunaif, A. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e197 · Cited by 224
Self-citationHolte, J., Bergh, T., Berne, C., & Lithell, H. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02577.x · Cited by 224
Kasuga, M., Hedo, J. A., Yamada, K. M., & Kahn, C. R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34032-8 · Cited by 220
Guzick, D. S., Talbott, E. O., Sutton-Tyrrell, K., Herzog, H. C., Kuller, L. H., & Wolfson, S. K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70665-8 · Cited by 212
Hereditary factors in the Stein-Leventhal syndrome
Cooper, H. E., Spellacy, W. N., Prem, K. A., & Cohen, W. D. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)33704-2 · Cited by 211
Willis, D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3788 · Cited by 210
Dunaif, A., & Graf, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113864 · Cited by 204
Self-citationSerum immunoreactive leptin concentrations in women with polycystic ovary syndrome
Brzechffa, P. R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.4166 · Cited by 204
Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance?
Nestler, J. E. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432767 · Cited by 201
DUNAIF, A., GREEN, G., FUTTERWEIT, W., & DOBRJANSKY, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-699 · Cited by 199
Self-citationMoghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.881 · Cited by 196
Freidenberg, G. R., Reichart, D., Olefsky, J. M., & Henry, R. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113744 · Cited by 195
Insulin resistance in polycystic ovary syndrome
Shoupe, D., Kumar, D. D., & Lobo, R. A. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90023-6 · Cited by 195
Leptin Concentrations in the Polycystic Ovary Syndrome1
Mantzoros, C. S., Dunaif, A., & Flier, J. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4017 · Cited by 194
Self-citationAndrogen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Mårin, P., Krotkiewski, M., & Björntorp, P. A. (1992) · PubMed · Cited by 192
The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia
Futterweit, W., Dunaif, A., Yeh, H.-C., & Kingsley, P. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70241-8 · Cited by 189
Self-citationPEIRIS, A. N., MUELLER, R. A., STRUVE, M. F., SMITH, G. A., & KISSEBAH, A. H. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-162 · Cited by 188
Sampson, M., Kong, C., Patel, A., Unwin, R., & Jacobs, H. S. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00863.x · Cited by 186
Effect of body weight reduction on plasma androgens in obese, infertile women
Bates, G. W., & Whitworth, N. S. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46571-4 · Cited by 185
LOBO, R. A., GOEBELSMANN, U., & HORTON, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-393 · Cited by 183
Clinical signs of androgen excess as risk factors for coronary artery disease
Wild, R. A., Grubb, B., Hartz, A., Van Nort, J. J., Bachman, W., & Bartholomew, M. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53699-1 · Cited by 183
Stadtmauer, L., & Rosen, O. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35797-6 · Cited by 182
el-Roeiy, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1488 · Cited by 181
Flier, J. S., Eastman, R. C., Minaker, K. L., Matteson, D., & Rowe, J. W. (1985) · Diabetes · doi:10.2337/diab.34.2.101 · Cited by 180
el-Roeiy, A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1411 · Cited by 178
Familial Clustering in the Polycystic Ovarian Syndrome
Lunde, O., Magnus, P., Sandvik, L., & Høglo, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000293493 · Cited by 177
Cellular and Molecular Mechanisms of Non-Insulin Dependent Diabetes Mellitus
Kruszynska, Y. T., & Olefsky, J. M. (1996) · Journal of Investigative Medicine · doi:10.1177/108155899604400806 · Cited by 176
Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay, Ö., & Gündoğdu, S. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58266-1 · Cited by 174
FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE?
HAGUE, W. M., ADAMS, J., REEDERS, S. T., PETO, T. E. A., & JACOBS, H. S. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03707.x · Cited by 174
Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes
Ryan, E. A., Imes, S. I., Liu, D., McManus, R., Finegood, D. T., Polonsky, K. S., & Sturis, J. (1995) · Diabetes · doi:10.2337/diab.44.5.506 · Cited by 171
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism
Apter, D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.10.2966 · Cited by 168
A twin study of polycystic ovary syndrome
Jahanfar, S., Eden, J. A., Warren, P., Seppälä, M., & Nguyen, T. V. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57412-3 · Cited by 166
Caro, J. F., Dohm, L. G., Pories, W. J., & Sinha, M. K. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050804 · Cited by 166
THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING
FERRIMAN, D., & PURDIE, A. W. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb03077.x · Cited by 161
Epidemiology of secondary amenorrhea
Fries, H., Nillius, S. J., & Pettersson, F. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33686-9 · Cited by 159
Laughlin, G. A., Morales, A. J., & Yen, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4028 · Cited by 158
Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A.
Guo, H., & Damuni, Z. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2500 · Cited by 158
Yki‐Järvinen, H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90229-4 · Cited by 157
Andersen, P., Seljeflot, I., Abdelnoor, M., Arnesen, H., Dale, P. O., Løvik, A., & Birkeland, K. (1995) · Metabolism · doi:10.1016/0026-0495(95)90118-3 · Cited by 156
Løbo, R. A., & Goebelsmann, U. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90095-2 · Cited by 156
Czech, M. (1982) · Cell · doi:10.1016/0092-8674(82)90399-3 · Cited by 152
Familial Polycystic Ovarian Disease
Givens, J. R. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30409-2 · Cited by 149
Rincón, J., Holmäng, A. B., Wahlström, E. O., Lönnroth, P., Björntorp, P. A., Zierath, J. R., & Wallberg‐Henriksson, H. (1996) · Diabetes · doi:10.2337/diab.45.5.615 · Cited by 149
Marshall, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89242-0 · Cited by 147
Obesity, lipids, cardiovascular risk, and androgen excess
Wild, R. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80056-4 · Cited by 145
Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance
Zimmermann, S., Phillips, R. A., Dunaif, A. E., Finegood, D. T., Wilkenfeld, C., Ardeljan, M., Gorlin, R., & Krakoff, L. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639952 · Cited by 144
Self-citationNormal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome
Ovesen, P., Møller, J. K., Ingerslev, H. J., Jørgensen, J. O. L., Mengel, A., Schmitz, O., Alberti, K. G. M. M., & Møller, N. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263152 · Cited by 144
Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
Norman, R. J., Masters, S. C., & Hague, W. M. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58687-7 · Cited by 144
Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464643 · Cited by 143
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
Nestler, J. E., & Strauss, J. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30245-7 · Cited by 141
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593446 · Cited by 140 · cited 1×
“Most oral contraceptive agents have been demonstrated to produce insulin resistance in normal women (162), and one study (267) found a worsening of insulin resistance during therapy with a combination oral contraceptive containing triphasic progestin (Novum 7/7/7, Ortho Pharmaceutical Corp, Raritan, NJ).”
BackgroundIbanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138
Assessment of insulin sensitivity in vivo: A critical review
Bergman, R. N., Hope, I. D., Yang, Y. J., Watanabe, R. M., Meador, M. A., Youn, J. H., & Ader, M. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050501 · Cited by 135
Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
Talbot, J. A., Bicknell, E. J., Rajkhowa, M., Krook, A., O’Rahilly, S., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626868 · Cited by 135
Dunaif, A. E., Sorbara, L. R., Delson, R., & Green, G. (1993) · Diabetes · doi:10.2337/diab.42.10.1462 · Cited by 131
Self-citationEhrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199801000-00017 · Cited by 129
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Mitrakou, A., Hennes, M. M. I., Platanisiotis, D., Kaklas, N., Spina, J., Georgiadou, E., Hoffmann, R. G., Kissebah, A. H., & Raptis, S. A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90062-4 · Cited by 128
Oppenheimer, E., Linder, B., & DiMartino-Nardi, J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852529 · Cited by 128
Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.
Rose, D. W., Saltiel, A. R., Majumdar, M., Decker, S. J., & Olefsky, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.797 · Cited by 123
Hyperinsulinemia in hyperthecosis of the ovaries
Nagamani, M., Dinh, T. V., & Kelver, M. E. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90676-9 · Cited by 122
Norman, R. J., Mahabeer, S., & Masters, S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57297-5 · Cited by 115
Waters, S. B., Yamauchi, K., & Pessin, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41513-x · Cited by 114
Lipid and apolipoprotein abnormalities in hirsute women
Wild, R. A., Alaupovic, P., & Parker, I. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90605-x · Cited by 112
Dunaif, A. E., Green, G., Phelps, R. G., Lebwohl, M., Futterweit, W., & LEWY, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-3-590 · Cited by 111
Self-citationInsulin resistance with acanthosis nigricans: The roles of obesity and androgen excess
Stuart, C. A., Peters, E. J., PRINCE, M. J., Richards, G. E., Cavallo, A., & Meyer, W. J. (1986) · Metabolism · doi:10.1016/0026-0495(86)90201-5 · Cited by 110
Prelević, G. M., Würzburger, M. I., Balint‐Peric, L., & Nešić, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92270-r · Cited by 109
Phosphorylation of Purified Insulin Receptor by cAMP Kinase
Roth, R. A., & Beaudoin, J. D. (1987) · Diabetes · doi:10.2337/diab.36.1.123 · Cited by 106
Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats
Holmäng, A. B., Larsson, B., Brzezinska, Z., & Björntorp, P. A. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.6.e851 · Cited by 106
Frattali, A. L., Treadway, J. L., & Pessin, J. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41806-6 · Cited by 105
Research works printed but not linked: 16
- Dunaif, 1992, Blackwell Scientific
- Dunaif, 1988, Insulin resistance and hyperandrogenism: clinical syndromes and possible mechanisms, In: Pancheri P, Zichella L (eds) Biorhythms and Stress in the Physiopathology of Reproduction. Hemisphere Publishing Co, Washington, DC, pp, 293
- Crowley, 1996, New tools for pituitary-gonadal assessment, In: Filicori M, Flagmini C (eds) The Ovary: Regulation, Dysfunction and Treatment. Elsevier, Amsterdam, pp, 287
- Achard, 1921, Le virilisme pilaire et son association a l’insuffisance glycolytique (diabete des femmes a barb)., Bull Acad Natl Med, 86, 51
- Kierland, 1947, Acanthosis nigricans: An analysis of data in twenty-two cases and a study of its frequency in necropsy material., J Invest Dermatol, 9, 299, 10.1038/jid.1947.102 · doi:10.1038/jid.1947.102
- Colle, 1979, Acanthosis nigricans, hirsutisme et diabete insulin-resistant., Arch Fr Pediatr, 36, 518
- Mechanick, 1990, Masculinization: a clinical approach to the diagnosis and treatment of hyperandrogenic women, In: Mazzaferri E (ed) Advances in Endocrinology and Metabolism. Mosley Year Book, Inc, Chicago, IL, pp, 129
- Fadden, 1995, Quantitative and selective fluorophore labeling of phosphoserine on peptides and proteins: characterization at the attomole level by capillary electrophoresis and laser-induced fluorescence., Anal Biochem, 225, 81, 10.1006/abio.1995.1111 · doi:10.1006/abio.1995.1111
- Dunaif, 1997, Diamanti E Defective insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
- Diamond, 1985, Human follicular fluid insulin concentrations., J Clin Endocrinol Metab, 61, 990, 10.1210/jcem-61-5-990 · doi:10.1210/jcem-61-5-990
- Hintz, 1984, IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides., Biochem Biophys Res Commun, 118, 774, 10.1016/0006-291X(84)91462-1 · doi:10.1016/0006-291x(84)91462-1
- Erickson, 1995, The ovarian connection, In: Adashi EY, Rock JA, Rosenwaks Z (eds) Reproductive Endocrinology, Surgery, and Technology. Raven Press, New York, pp, 1141
- Mason, 1996, Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries., J Clin Endocrinol Metab, 81, 276
- Dunaif, 1996, Book C-B Selective intrinsic defects in insulin and IGF-1 action in polycystic ovary syndrome (PCOS) in skin fibroblasts
- Dunaif, 1996, The insulin sensitizing agent troglitazone: a novel therapy for the polycystic ovary syndrome., J Clin Endocrinol Metab, 81, 3299
- Gharani, J Clin Endocrinol Metab, 81, 4174
Cited by
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Metadata
- Authors
- Dunaif, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1997-12-01
- Volume
- 18
- Issue
- 6
- Pages
- 774-800
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2100211815
- Cited by
- 2,458
- References
- 274
- FWCI
- 35.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.